TREES Total Liabilities 2014-2024 | CANN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TREES total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TREES total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228.8B
Boston Scientific (BSX)	$156.9B
Stryker (SYK)	$150.3B
EssilorLuxottica (ESLOY)	$143.8B
Medtronic (MDT)	$118.1B
Lonza Group Ag (LZAGY)	$50B
Haleon (HLN)	$43.5B
ResMed (RMD)	$41.3B
GE HealthCare Technologies (GEHC)	$33.9B
Agilent Technologies (A)	$33.7B
Terumo (TRUMY)	$26.9B
Koninklijke Philips (PHG)	$26.7B
Insulet (PODD)	$23.5B
Zimmer Biomet Holdings (ZBH)	$21.2B
Smith & Nephew SNATS (SNN)	$16.3B
Baxter (BAX)	$12.6B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.9B
Lantheus Holdings (LNTH)	$3.9B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.7B
LeMaitre Vascular (LMAT)	$2.2B
Curaleaf Holdings (CURLF)	$2.1B
Acuren (TIC)	$2.1B
QuidelOrtho (QDEL)	$1.9B